Philip Morris
Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
Fields
- Author
- Bridges, R.B.
- Humble, J.W.
- Rehm, S.R.
- Turbek, J.A.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Ahf, American Health Foundation
- Univ of Kt
- Named Person
- Combs, J.
- Haley, N.
- Reed, D.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Univ of Kt
- Va Medical Center
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
I
I
1
I
I
I
I
I
I
I
I
I
I
Eur J Respir Dis (1986) 69 (Suppl. 146), 129-137
SMOKING HISTORY, CIGARETTE YIELD AND SMOKING BEHAVIOR
AS DETERIMINANTS OF SMOKE EXPOSURE.
R. B. BRIDGES1, J. W. HUMBLE2, J. A. TURBEK2 AND S. R. REHM3
1: Oral Biology, Dentistry, University of Kentucky, Lexington, KY.
2: Tobacco and Health Res. Inst., Univ. of Kentucky, Lexington, KY.
3: Medicine, VA Medical Center, Lexington, KY.
ABSTRACT
This study examines how smoking history, cigarette yield and
smoking behavior relate to smoke exposure as determined by smoke
constituents and their metabolic products in peripheral blood.
Recruited without regard to the nicotine yield of their cigarette,
male smokers smoked their own cigarettes j" libitum, including one
cigarette five minutes prior to venipuncture. Smokers had signifi-
cant (p=0.0001) elevations of serum thiocyanate, blood carboxyhemo-
globin, plasma nicotine, and cotinine concentrations each of which
was significantly associated with past 24-hour cigarette consump-
tion. The nicotine yield of the cigarette significantly correlated
with plasma cotinine concentrations and with the smoking behavior
variables. Most notably, smokers consuming lower nicotine yielding
cigarettes exhibited an increased total puff volume per cigarette,
suggesting that smokers of low nicotine yielding cigarettes compen-
sate for these low yields by their smoking behavior. However, the
fact that lower plasma cotinine concentrations are present in
smokers of low-nicotine cigarettes suggests that this compensation
is incomplete. That smoking behavior variables relate to smoke
exposure was demonstrated by a significant linear correlation be-
tween plasma nicotine and mean puff interval in the total smoking
population and between plasma nicotine and total puff volume per
cigarette in a subpopulation smoking a single brand of cigarette.
These data suggest that smoking history, nicotine yield of the
cigarette and smoking behavior are all determinants of smoke expo-
sure. Further, although smokers of low-yield cigarettes appear tc
compensate by puffing larger volumes per cigarette, this compensa-
tion appears to be inadequate to attain an equivalent smoke expo-
sure. Thus, if tobacco related obstructive pulmonary diseases are
associated with increased smoke exposure, a lesser degree of lung
injury may be expected in smokers using low-yield cigarettes.
INTRODUCTION
Aside from possible genetic or other individual differences in
susceptibility, the development of obstructive lung disease is
likely related to a dose-dependent exposure to cigarette smoke
(13). The exposure to the components of cigarette smoke is com-
plex, being dependent upon a number of variables, some of which are
interrelated. These variables include: the yield of the cigarette
smoked; the present and cumulative smoking history; the smoking
behavior (e.g., puff volume, duration and interpuff interval); and
the absorption of smoke constituents (7). The absorption of smoke
constituents is in itself dependent upon smoke chemistry, inhala-
tion behavior, lung morphology and other physiologic parameters.
The purpose of this cross-sectional study was to ascertain the
major determinants of cigarette smoke exposure in a group of rela-
tively young smokers with the ultimate intent of attempting to
relate this smoke exposure to the development of obstructive lung
disease. Cigarette smoke exposure was ascertained by measuring
blood concentrations of smoke constituents/metabolites including
thiocyanate, carboxyhemoglobin, nicotine and cotinine. We then
129

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
ti
sought to determine how parameters of cigarette consumption,
yield of the cigarette smoked, and smoking behavior related to
smoke exposure.
T_HODS
METHODS
For this study, 170 male smokers were recruited without re
to the yield of the cigarette smoked or smoking history and
pared with 170 age-matched male non-smokers . Subjects for
study completed an extensive questionnaire concerning medical
pulmonary histories, tobacco and drug usage, alcohol and cc
consumption, and demographics. Nine smokers and two non-smc
indicating uses of tobacco products other than cigarettes
excluded from the data analysis. Smokers provided data on ci
ette brand and number of cigarettes smoked per day for each f
year interval to the present time. The nicotine yield of
cigarette smoked was determined from lists available from
Federal' Trade Commission (8). Smokers were requested to smokE
libitum and to smoke one of their own cigarettes at 8 am,
minutes prior to venipuncture. This latter cigarette was sa
using a cigarette holder-pneumotachograph to measure number
puffs, intervals between puffs, duration and volume of each
and total volume puffed per cigarette (1). This pneumotachoE
was calibrated by drawing puffs of standard volume inserting
subject's unlit cigarette in the cigarette holder. The t
concentrations of smoke constituents/metabolites were determin<
previously described (6).
Statistical analysis of the data utilized Student's t test
unpaired data and Pearson's correlates for regresaion ana:
using appropriate SAS programs (10) and an IBM 3083 computer.
data are expressed as means tS.E.M.
RESULTS
The characteristics of the smoking and nonsmoking popula,
are given in Table i. The smoking and nonsmoking population:
not differ significantly in age, weight or tea consumption.
ever, the smokers consumed significantly more coffee and alcol
beverages than did their nonsmoking counterparts.
Table 1. Characteristics of Smoking and Nonsmoking Population:
Nonsmokers Smokers P
Age (years) 37.2:0.8 37.8t0.8 0.59
Weight (1Cg) 79.6t1.0 77.6t0.9 0.13
Tea Consuaptiont 1.02=0.12 0.94t0.15 0.72
Coffee Consumptiont 1.70=0.18 3.8g=0.30 0.0001
Alcohol Consu.ption$ 2.55t0.29 8.73t1.06 0.0001
Results for 161 smokers and 168 nonsmokers.
tExpressed as cups per day.
$Expressed as ounces of pure alcohol consumed per week.
There was considerable variability among smokers in term
the smoking history parameters (Table 2). Consistent with
relatively young age, the smokers had a relatively brief sm
history (20.3 years smoking, 24.6 pack-years) and had smoked a
of 25 cigarettes in the past 24 hours. The smokers consum
variety of cigarette products including both non-filter and f
cigarettes, with a relatively high mean nicotine yield (1.0 mg
arette) for the overall population.
As expected, smokers had significantly (pS0.0001) higher
thiocyanate, blood carboxyhemoglobin, and plasma nicotine and
nine concentrations than did the nonsmokers (Table 3). F

I
I
I
I
I
I
I
I
I
I
I
Table 2. Smoking Historyf
MEAN t S.E.M.
RANGE
Nicotine yield 1.00 t 0.02 0.28-1.56
Cigarettes past 24 hours 24.8 t 0.9 5-70
Years smoking 20.3 t 0.9 3.7-53.7
Pack-years 24.6 t 1.0 3.8-60.0
Data for 161 smokers.
nicotine and cotinine concentrations, being specific markers for
tobacco smoke exposure, were the better indicators to differentiate
between smokers and nonsmokers (data not shown). Significant
linear correlations existed between the log of the cigarettes
consumed in the past 24 hours and the blood c~~centrations of each
of the smoke constituents/metabolites. In each case the log of
the cigarettes in the past 24 hours was a better predictor of Hood
concentrations of smoke constituents/metabolites than were the
linear plots. However, the log of the cigarettes consumed in the
past 242hours was the best predlgtor of plasma cotinine concentra-
tion (R =0.132, pS0.0001) (Fig. 1), followed2in order by carboxy-
hemoglobin (R 20.101, ps0.0001), nicotine (R =0.058, pS0.002) and
thiocyanate (R =0.033, pS0.02).
Table 3. Blood Concentrations of Smoke Constituents/Metabolitese.
Nonsmokers Smokers P
Serum Thiocyanate ( u M) 98.3t2.6 163.43.7 0.0001
Carboxyhemoglobin () 2.2.t0.1 7.at0.2 0.0001
Plasma Nicotine (ng/ml) 2.30.3 31.1t1.3 0.0001
Plasma Cotinine (ng/ml) 2.9t0.4 384.0t12.5 0.0001
Results for 161 smokers and
168 nonsmokers.
r.0.373
080.0001
.n
E
w
c
v
W
2_
~
U
. - ~
2 300 J ' 00 _ ~ .
40
.
~
~ <
20o
f- -
2 '
J
d . . .
s .
Ioo
o . -
C - .
.
ZZJ
5 10 iS 20 30 40 50 60 70 6"
CIGARETTES PAST 24 HOURS al~
Fig. 1. Relationship of p lasm a cotinine conc en tration with ~
cigarette consumpti on i n the past 24 hou rs . ~
~
~ The smoking population was arb itrarily divided into six groups I-~
according to relatively narro w ra nges of nicotine yield of their ~
cigarettes (Table 4). Smokers of high-nicotine cigarettes in
groups 5 and 6 had significantl y di fferent mean age, years smoked
I - - 131

I
I
I
I
I
I
I
I
I
I
I
I
I
I
y
and pack-years smoking history than did those in the first
groups. Therefore, in order to avoid the possible complicatin
effects of age and smoking history characteristics, further statis
tical analyses were limited to groups 1 through 4.
Table 4. Characteristics of Smokers According to Nicotine Yield 0
Their Cigarette.
Range of
Nicotine
Group Yield
N
Age
(years) Cigarettes
Past 24
Hours
Years
Smoked
Pack-Year
1 0.28-0.43 5 36.1t2.5 19.4t5.4 16.8t3.0 23.8t7.2
2 0.50-0.70 16 35.2f2.2 23.1t2.6 15.9±1.7 20.2±2.6
3 0.71-0.90 22 40.0t2.8 24.7t6.6 20.5f2.9 23.5t6.7
4 1.05-1.10 65 36.1t1.2 25.6±1.6 19.1±1.2 24.1t1.5
5 1.11-1.20 17 30.6.t1.4t 24.2t2.6 13.5t1.5t 16.4±2.2
6 1.40-1.60 14 48.4t2.it 24.1±3.0 33.9t2.6 t 37.9t3.2
fTwenty-two subjects smoked generic cigarettes for which th
nicotine yield was unavailable.
tSignificantly (pS0.05) different from groups 1 through 4.
The blood concentrations of smoke constituents/metabolites ii
the first 4 groups are given in Table 5. Although smokers of low
yield cigarettes had lower plasma nicotine and cotinine concentra
tions than did smokers of higher yield cigarettes, these decreasec
concentrations were not proportionate to the relative decrease ir
yield of the cigarette smoked. For example, comparing smokers ir
groups 4 and 1, there was a 68% decrease in the mean nicotine yielc
of the cigarettes with only a 44.6% and 37.4% decrease in mear
plasma nicotine and cotinine concentrations, respectively.
Although serum thiocyanate and blood carboxyhemoglobin were alsc
decreased (19.2% and 25%, respectively), these decreases were
smaller in magnitude, suggesting that exposure to the gas phase
components of cigarette smoke (i.e., cyanide and carbon monoxide)
remained relatively high despite the reduction in the principal
pharmacologic agent of the particulate phase, nicetine.
Table 5. Blood Concentrations of Smoke Constituer.ts/Metabolites in
Groups of Smokers According to Nicotine Yield of their
Cigarettef.
Mean
Nicotine
Carboxy-
Plasma
Plasma
Tield Thiocyanate hemoglobin Nicotine Cotinine
Grcup (mg/cigarette) ( pmoles/1) (S) (ng/ml) (ng/ml)
1 0.34 132.2t17.5 5.7f1.0 18.0t1.4 256t92
2 0.56 160.7t 9.1 7.4.0.6 29.7t5.3 330±37
3 0.76 175.9±11.3 7.6±0.5 28.4s3.1 351±28
4 1.06 163.6t 6.0 7.6t0.3 32.5±1.7 409t19
g Change* -68% -19.2% -25% -44.6% -37.4%
The percentage change in the means comparing groups 4 and 1
That the yield of the cigarette affects exposure to smoke was
verified by the linear relationships between yield and plasma
nicotine or cotinine concentrations. The nicotine yield of the
cigarette correlated marginally with plasma nicotine (r=0.168,
p:0.08) and significantly with plasma cotinine (Fig. 2). However,
the yield of the cigarette did not correlate significantly with
either serum thiocyanate (r=0.082, pa0.4) or blood carboxyhemo-
Llobin (r=0.105. p=0,29) concentrations.
132
I
\
00

I
I
I
I
I
I
I
1
I
I
I
I
I
I
I
1
I
I
~
E
aa
~
W
2
2
O
U
Q
900
eoo
700
600
500
400
2
to 300
Q
a 200
loo
y= 1 74.0:+222.9
r=0.257
os0.00s
. ' . . .: _
.:
~ . . .
.~ .
. . .
. .
.
. .
. ~.
~
. : . .
. . .
. . ...
.
. . . .
. . ~
. :
. . .
..
. .
.
.
.
.
041.
~ . x
~0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1
.I 1.2
NlCOTNE YlELD (eg/ciyar.tt.)
Fig. 2. Relationship of plasma cotinine with the
the cigarette smoked.
nicotine yield of
The smoking behavior variables for the first 4 groups of
smokers according to the nicotine yield of their cigarettes are
given in Table 6. Although not significant, smokers consuming the
lowest nicotine yielding cigarettes (group 1) tended to have a
higher number of puffs per cigarette. However, these smokers had a
significantly higher mean puff volume (pS0.001) as compared to the
other 3 groups. These changes in smoking behavior probably account
for the highly significant (pS0.0001) increase in total puff volume
observed in the saiokers of low-yield products in group 1. Further,
a highly signif:.cant linear decrease in total puff volume per
cigarette was observed with increasing nicotine yield in these four
groups of smokers (Fig. 3).
Table 6. Smoking Behavior in Groups of Smokers According to the
Nicotine Yield of their Cigarettef.
Group
1 Number of
Puffs Per
Cigarette
13.2t2.8 Mean Puff
Volume
(milliliters)
85.4t10.60 Total Volume
Per Cigarette
(milliliters)
1141.6.t281.4t
2 11.4t1.4 63.7t 8.0 686.4t 89.7
3 11.1.t0.9 54.1t 2.6 577.9t 40.8
4 10.6t0.5 52.2t 1.8 528.% 20.3
fSignificantly (pS0.001) greater than the other groups (2-4).
tSignificantly (p5 0.0001) greater than the other groups (2-4).
The importance of studying smoking behavior variables is
dependent upon the ability to demonstrate relationships between
these variables and the blood concentrations of smoke constituents
/metabolites. Examination of the linear correlates between these
smoking behavior variables and blood concentrations of smoke con-
stituents/metabolites of smokers in groups 1 thru 4 (Table 7)
revealed relatively few significant, linear correlations. Signifi-
cant negative correlations were observed between serum thiocyanate
concentrations and the mean puff volume and the total volume per
cigarette. The rationale for these significant correlations is not
133

1
~
1
~
~
~
~
~
1
~
~
1
~
~
1
V
= r--48S.0. + 1023
~
~ 2000 P.-0.407
10.0001
S 1800
1600
W
1400
1
V 1200
1000
~ .
~
800 . .
W . :.S
W 600 .
. .
. ~~
. .S
0 . . . ...~-
.
400 . : .~ ~
~.
4 ..
. -ILI :
. - «
p 200 F
~
0.1
0.2
0.3
0.4
0.5 0.6
0.7 0.8
0.9
1.0 1.1 x
1.2
NICOTTE YELD */ciparntt.)
Fig. 3. Relationship of total puff volume per cigarette with tt
nicotine yield of the cigarette smoked.
Table
7.
Relationships of Smoking Behavior with Blood
Concentrations of Smoke Constituents/Metabolitesf.
Serum Carboxy- Plasma Plasma
Thiocyanate
# Puffs/cigarette -0.088 hemoglobin
0.046 Nicotine
0.125 Cotinine
0.016
Mean puff interval 0.048 -0.093 -0.295t -0.114
Mean puff volume -0.195t -0.070 -0.039 -0.139
Total volume/cigarette -0.225t -0.054 0.058 -0.117
*Pearson's correlates for 108 smokers (Groups 1 tarough 4)
tp50.05
tpS0.01
40
35
30
25
20
IS
10
5
0
240
360 480 6o0' 720 840 940 1080
TOTAL PtFF VOLtJ1/E /CiGARfTTE (.it.n)
Fig. 4. Relationship between plasma nicotine concentration an
total volume puffed per cigarette in a populatio
smoking a single brand of cigarette (nicotine yield 1.0
me/ciQarette).
134
~

I
I
I
I
I
I
I
1
I
I
I
I
I
I
I
I
I
apparent. A significant, negative correlation was also observed
between plasma nicotine and the mean puff interval. Although a
significant correlate was expected between total puff volume and
plasma nicotine, none was detected in the total smoking population.
Since nicotine yield of the cigarette had already been shown
to affect smoking behavior variables, it seemed likely that the
variation in nicotine yield might confound any significant linear
relationships between smoking behavior variables and plasma nico-
tine. Therefore, the relationships between smoking behavior vari-
ables in smokers with an equivalent nicotine yielding cigarette
were sought in the largest, available sub-population of smokers
consuming the same brand of cigarette. Thirty smokers in this
study consumed a single brand of cigarette with a nicotine yield of
1.05 mg/cigarette. In addition to the significant negative corre-
lation between mean puff interval and plasma nicotine concentration
(r=0.438, p=0.02), the total volume per cigarette was also signifi-
eantly correlated with plasma nicotine (Fig. 4). On the other
hand, number of puffs was only marginally related to plasma nico-
tine (r=0.306, p=0.10).
DISCUSSION
0o concentrations of thiocyanate, carboxyhemoglobin, nico-
tine and cotinine are at best only estimates of smoke exposure.
The concentrations of these constituents, while related to smoke
exposure, are also dependent upon pharmacokinetic parameters such
as volume of distribution, clearance time and half-life (7).
In this study, we sought to determine how cigarette consump-
tion, nicotine yield of the cigarette and smoking behavior relate
to cigarette smoke exposure as measured by blood concentrations of
these smoke constituents/metabolites. This cross-sectional study
differs from other previous studies in that these parameters were
determined in a relatively large population of healthy, male smo-
kers who smoked ad libitum their own brand of cigarette. In
addition, the sub7ect~or this study were not selected according
to indices of smoking history or type of cigarette smoked, accoun-
ting for the observed large variation in these parameters. By
selecting the subject population in this manner, relationships
between parameters were not optimized due to the confounding
effects of the other variables. However, the study population is
probably more representative of the general smoking population and
no changes in the smokers' habits have been introduced by the
experimental design.
The best indicator of cigarette consumption in the past 24
hours was p1asms cotinine probably as a result of both it: rela-
tively long half-life (15.8 hours) (4) and its specificity as an
indicator of cigarette smoke exposure. However, 24-hour cigarette
consumption still accounted for only 13.9% of the variation in
plasma cotinine concentration. Although blood concentrations of
carboxyhemoglobin are affected by exposure to environmental carbon
monoxide, physical activity and a relatively short half-life of 2-4
hours (15), it was still a good indicator of cigarette consumption
in the past 24 hours. On the other hand, nicotine [as a result of
its short half-life of 1.9 hours (11)] and thiocyanate [being
affected by diet (5) and having a half-life of 14 days (9)] were
relatively poor indicators of cigarette consumption in the past 24
hours.
Controversy exists in the literature as to the relation be-
tween blood levels of smoke constituents and the nicotine yield of
the cigarette (2,11). In the present study, we have demonstrated
that the nicotine yield of the cigarette affects the blood concen-
trations of smoke constituents/metabolites, especially cotinine.
135

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
y
Dividing the smoking population in groups according to the nicotir,
yield of the cigarette smoked, a trend toward decreased concentra
tions of all smoke constituents/metabolites was observed with th
lower nicotine yield of the cigarettes. Decreased plasma nicotin
and cotinine concentrations were linearly associated with decrease
nicotine yield of the cigarette smoked, without taking into accoun
individual differences in daily cigarette consumption. However
these decreases in plasma nicotine or ootinine were not equivalen
to the decrease in nicotine yield of the cigarettes, suggesting a
incomplete compensation by smokers of low-yield cigarettes.
Previous studies have demonstrated compensation by smokers o
low-yield cigarettes by means of either increased cigarett~
consumption (12) or changes in smoking behavior (8). Compensatioi
in the present study was not due to increases in cigarette consump
tion since all the groups had an equivalent mean daily cigarett(
consumption. Therefore, we sought to determine if compensation b:
smokers of low-yield cigarettes was due to differences in smokinE
behavior. A highly significant increase in total puff volume per
cigarette was observed in smokers of low-yield cigarettes. Thi:
increased total puff volume per cigarette appeared to be due t(
increases in both the number of puffs per cigarette and the mear
puff volume. Further, a significant linear increase in tota:
volume per cigarette was observed with decreasing nicotine yielc
for this total population of smokers. Collectively, these datz
suggest that smokers of low-yield cigarettes compensate primaril}
by puffing a larger, total volume per cigarette.
Relationships between the smoking behavior variables and thE
blood concentrations of smoke constituents/metabolites were alsc
sought in order to demonstrate that these variables are related tc
smoke exposure. Due to its relatively short half-life and speci-
ficity, plasma nicotine seemed more likely to correlate with these
smoking behavior variables. In the total smoking population,
plasma nicotine concentration was observed to increase with
decreasing mean puff intervals. This observation is consistent
with the fact that shorter intervals between puffs raises the
pyrolysis temperature of the burning cigarette rod and thus, in-
creases the nicotine delivery. No significant linear relationship
was observed between total puff volume per cigarette and plasma
nicotine in the total smoking population. However, removing the
confounding effects of nicotine yield by studying a sub-group of
smokers consuming the same brand of cigarette, linear increases in
plasma nicotine concentration were significantly associated with
both decreased intervals between puffs and increased total puff
volume per cigarette. These data demonstrate that smoking behavior
variables, especially puff interval and total puff volume per
cigarette, are determinants of smoke exposure.
Thus, in a cross-sectional study of a well-delineated group of
relatively young smokers, we have observed that cigarette smoke
exposure (espeoially as measured by plasma nicotine and cotinine
concentrations) is dependent upon: i.) daily cigarette consump-
tion; ii.) the yield of the cigarette smoked; and iii.) smoking
behavior. Smokers of low-yield cigarettes appear to compensate for
these lower yields by taking significantly larger puffs and a trend
toward a larger number of puffs, but not by an increased cigarette
consumption. Despite these compensatory mechanisms in smokers of
low-yield cigarettes, these smokers did not achieve the same smoke
dose as smokers of high-yield cigarettes. Thus, if tobacco related
pulmonary diseases are associated with increased smoke exposure, a
lesser degree of lung injury may be expected in smokers using low-
yield cigarettes.
136

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
ACKNOWLEDGEMENTS
We thank Ms. Judy Combs for expert technical assistance; Ms.
Donna Reed for data entry; and Dr. Nancy Haley of the American
Health Foundation, Valhalla, N.Y. for the nicotine and cotinine
analyses. This study was supported by grants from the Tobacco and
Health Research Institute, University of Kentucky, Lexington, KY.
REFERENCES
1. Anderson W.H., Bright M., Snider H.L.: Relation of smoking to
cardiopulmonary disease. IN: Proceedings of the 5th Workshop
Conference of the Tobacco and Health Research Institute of the
University of Kentucky, November 1-2, 1979.
2. Benowitz N.L., Hall S.M., Herning R.I., Jacob P. (III), Jones
R.T., Osman A.-L.: Smokers of low-yield cigarettes do not
consume less nicotine. N. Engl. J. Med. 309: 139-142, 1983.
3. Benowitz N.L., Jacob P.(III), Jones R.T., Rosenberg J.:
Interindividual variability in the metabolism and
cardiovascular effects of nicotine in man. J. Pharm.
Exper. Ther. 221: 368-372, 1982.
4. Benowitz N.L. Kuyt F., Jacob P.(III), Jones R.T., Osman A.-L.:
Cotinine disposition and effects. Clin. Pharm. Ther. 34: 604-
611, 1983
5. Borgers D., Junge B. Thiocyanate as an indicator of tobacco
smoking. Prev. Med. 8: 351-357, 1979.
6. Bridges R.B., Rehm S.R., Wyatt R.J.: Increased plasma
concentrations of C9, Cl-inhibitor and a1-protease inhibitor
associated with cigarette smoking. Life Sci. 36: 955-963,
1985.
7. Darby T.D., McNamee J.E., van Rossum J.M.: Cigarette smoking
pharmacoki"tics and its relationship to smoking behavior.
Clin. Pharmacokinetics 9: 435-449, 1984.
8. FEDERAL TRADE COMMISSION: Report of "Tar", Nicotine and Carbon
Monoxide of the Smoke of 207 Varieties of,Domestic Cigarettes.
February 1984.
9. Prue D.M., Martin J.E., Humbe A.S.: A critical evaluation of
thiocyanate as a biochemical index of smoking exposure.
Behav. Ther. 11: 368-379, 1980.
10. Ray, A.A. Ed. SAS User's Guide: Statistics. Cary, North
Carolina: SAS Institute, 1982.
11. Russell M.A.H., Sutton S.R.,' Iyer R., Feyerabend C., Vesey
C.J.: Long-term switching to low-tar low-nicotine cigarettes.
Br. J. Addict. 77: 145-158, 1982.
12. Stepney R.: Consumption of cigarettes of reduced tar and
nicotine delivery. Br. J. Addict. 75: 81-88, 1980.
13. Surgeon Ceneral: Smoking and Health: A report of the Surgeon
General U.S. Department of Health, Education and Welfare
Publication No. (PHS) 79-50066 (1979).
14. Tobin M.J., Sackner M.A.: Monitoring smoking patterns of low
and high tar cigarettes with inductive plethysmography. Am.
Rev. Respir. Dis. 126: 258-264, 1982.
15. Wald N., Howard S., Smith P.C., Bailey A.: Use of
carboxyhaemoglobin levels to predict the development of
diseases associated with cigarette smoking. Thorax 30: 133-
140, 1975.
07
